Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 2
2006 1
2007 1
2011 1
2013 1
2014 5
2015 8
2016 5
2017 4
2018 8
2019 4
2020 9
2021 5
2022 10
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP.
Vianello E, Persson J, Andersson B, van Veen S, Dias TL, Santoro F, Östensson M, Obudulu O, Agbajogu C, Torkzadeh S; VSV-EBOVAC; VSV-EBOPLUS Consortia; Nakaya HI, Medaglini D, Siegrist CA, Ottenhoff THM, Harandi AM. Vianello E, et al. iScience. 2023 Nov 23;26(12):108574. doi: 10.1016/j.isci.2023.108574. eCollection 2023 Dec 15. iScience. 2023. PMID: 38162033 Free PMC article.
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.
Gonzalez Dias Carvalho PC, Dominguez Crespo Hirata T, Mano Alves LY, Moscardini IF, do Nascimento APB, Costa-Martins AG, Sorgi S, Harandi AM, Ferreira DM, Vianello E, Haks MC, Ottenhoff THM, Santoro F, Martinez-Murillo P, Huttner A, Siegrist CA, Medaglini D, Nakaya HI. Gonzalez Dias Carvalho PC, et al. Among authors: haks mc. Front Immunol. 2023 Nov 8;14:1259197. doi: 10.3389/fimmu.2023.1259197. eCollection 2023. Front Immunol. 2023. PMID: 38022684 Free PMC article.
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity.
Eckold C, van Doorn CLR, Ruslami R, Ronacher K, Riza AL, van Veen S, Lee JS, Kumar V, Kerry-Barnard S, Malherbe ST, Kleynhans L, Stanley K, Joosten SA, Critchley JA, Hill PC, van Crevel R, Wijmenga C, Haks MC, Ioana M, Alisjahbana B, Walzl G, Ottenhoff THM, Dockrell HM, Vianello E, Cliff JM; TANDEM Consortium$. Eckold C, et al. Among authors: haks mc. Clin Transl Med. 2023 Sep;13(9):e1375. doi: 10.1002/ctm2.1375. Clin Transl Med. 2023. PMID: 37649224 Free PMC article.
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi M, Huang H, Wang C, Xia Q, Rozot V, Krishnan A, Acs P, Cheruku A, Obermoser G, Leslie A, Behar SM, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Walzl G, Hatherill M, Davis MM, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium. Musvosvi M, et al. Nat Med. 2023 Jan;29(1):258-269. doi: 10.1038/s41591-022-02110-9. Epub 2023 Jan 5. Nat Med. 2023. PMID: 36604540 Free PMC article.
Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R, Heemskerk MT, Forn-Cuní G, Korbee CJ, Walburg KV, Esselink JJ, Carvalho Dos Santos C, de Waal AM, van der Hoeven DCM, van der Sar E, de Ries AS, Xie J, Spaink HP, van der Vaart M, Haks MC, Meijer AH, Ottenhoff THM. Boland R, et al. Among authors: haks mc. mBio. 2023 Feb 28;14(1):e0302422. doi: 10.1128/mbio.03024-22. Epub 2022 Dec 7. mBio. 2023. PMID: 36475748 Free PMC article.
Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in humans.
Bahrami F, Masoudzadeh N, Van Veen S, Persson J, Lari A, Sarvnaz H, Taslimi Y, Östensson M, Andersson B, Sharifi I, Goyonlo VM, Ottenhoff TH, Haks MC, Harandi AM, Rafati S. Bahrami F, et al. Among authors: haks mc. Mol Immunol. 2022 Sep;149:165-173. doi: 10.1016/j.molimm.2022.07.008. Epub 2022 Jul 26. Mol Immunol. 2022. PMID: 35905592 Free article.
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment.
van Doorn CLR, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee JS, Kumar V, Kerry-Barnard S, Malherbe ST, Kleynhans L, Stanley K, Hill PC, Joosten SA, van Crevel R, Wijmenga C, Critchley JA, Walzl G, Alisjahbana B, Haks MC, Dockrell HM, Ottenhoff THM, Vianello E, Cliff JM; TANDEM Consortium. van Doorn CLR, et al. Among authors: haks mc. EBioMedicine. 2022 Aug;82:104173. doi: 10.1016/j.ebiom.2022.104173. Epub 2022 Jul 15. EBioMedicine. 2022. PMID: 35841871 Free PMC article.
67 results